Skip to content

HealthLynked Corp.: 10-Q filed 2018-11-14

What HealthLynked Corp. reported in its quarterly report filed 2018-11-14 (fiscal Q3 2018): 31 published measures, 87 facts as tagged in accession 0001213900-18-015759.

This filing

Form
10-Q (quarterly report)
Filed
2018-11-14
Fiscal period
fiscal Q3 2018
Accession
0001213900-18-015759 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HealthLynked Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-09-301,160,921USD
At 2017-12-31439,783USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-09-303,165,224USD
At 2017-12-312,491,196USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-09-30-2,004,303USD
At 2017-12-31-2,051,413USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-09-30803,491USD
At 2017-12-3150,006USD
At 2017-09-3016,175USD
At 2017-06-3057,600USD
At 2016-12-3158,716USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-2,209,738USD92
2018-01-01 to 2018-09-30-4,601,095USD273
2017-07-01 to 2017-09-30-920,322USD92
2017-01-01 to 2017-09-30-1,958,747USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-1,910,098USD273
2017-01-01 to 2017-09-30-1,131,324USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-09-30201USD273
2017-01-01 to 2017-09-3013,238USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-09-302,663,784USD273
2017-01-01 to 2017-09-301,102,021USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-201USD273
2017-01-01 to 2017-09-30-13,238USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-09-30-9,306,325USD
At 2017-12-31-4,705,230USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-07-01 to 2018-09-3079,323,131shares92
2018-01-01 to 2018-09-3076,757,809shares273
2017-07-01 to 2017-09-3069,625,763shares92
2017-01-01 to 2017-09-3068,805,330shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-07-01 to 2018-09-3079,323,131shares92
2018-01-01 to 2018-09-3076,757,809shares273
2017-07-01 to 2017-09-3069,625,763shares92
2017-01-01 to 2017-09-3068,805,330shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-0.03USD/shares92
2018-01-01 to 2018-09-30-0.06USD/shares273
2017-07-01 to 2017-09-30-0.01USD/shares92
2017-01-01 to 2017-09-30-0.03USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-0.03USD/shares92
2018-01-01 to 2018-09-30-0.06USD/shares273
2017-07-01 to 2017-09-30-0.01USD/shares92
2017-01-01 to 2017-09-30-0.03USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-09-3045,775USD
At 2017-12-3163,376USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-966,383USD92
2018-01-01 to 2018-09-30-2,072,892USD273
2017-07-01 to 2017-09-30-512,153USD92
2017-01-01 to 2017-09-30-1,382,213USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-09-301,105,606USD
At 2017-12-31366,867USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-07-01 to 2018-09-3058,655USD92
2018-01-01 to 2018-09-30150,008USD273
2017-07-01 to 2017-09-3027,124USD92
2017-01-01 to 2017-09-3064,921USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-09-301,734,811USD
At 2017-12-312,469,790USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-09-30133,902USD
At 2017-12-31113,349USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-07-01 to 2018-09-301,506,008USD92
2018-01-01 to 2018-09-303,824,476USD273
2017-07-01 to 2017-09-30992,876USD92
2017-01-01 to 2017-09-302,855,852USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-09-3082,536,893shares
At 2017-12-3172,302,937shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-09-307,279,226USD
At 2017-12-312,638,311USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-09-30791,968USD
At 2017-12-31791,767USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-09-30746,193USD
At 2017-12-31728,391USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-2,209,738USD92
2018-01-01 to 2018-09-30-4,601,095USD273
2017-07-01 to 2017-09-30-920,322USD92
2017-01-01 to 2017-09-30-1,958,747USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-30896,754USD92
2018-01-01 to 2018-09-302,024,165USD273
2017-07-01 to 2017-09-30480,614USD92
2017-01-01 to 2017-09-301,369,018USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-1,243,355USD92
2018-01-01 to 2018-09-30-2,528,203USD273
2017-07-01 to 2017-09-30-408,169USD92
2017-01-01 to 2017-09-30-576,534USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-01-01 to 2018-09-3031,863USD273
2017-01-01 to 2017-09-301,002USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-01-01 to 2018-09-302,520,192USD273
2017-01-01 to 2017-09-30548,356USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-3020,553USD273
2017-01-01 to 2017-09-30-28,293USD273

Inspect the source

Entity
HealthLynked Corp. / CIK 0001680139
Captured
2026-09-21T17:24:54.848Z
SEC response SHA-256
1d7da97d254ed8ecb29a71cd1691cea4f80024d23346bfec1c2cf84b10f19e3f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001680139.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))